Lactobacillus johnsonii N6.2
Cell therapyexperimental
Clinical trial activity
7 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2015 (NCT02349360)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- microbiotaTissue restoration
microbiota tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- l. johnsonii n6.2
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07191405 | N/A | Sep 18, 2025 | Zhejiang University |
| NCT06866990 | N/A | Mar 31, 2025 | Zhejiang University |
| NCT06823323 | N/A | Mar 1, 2025 | Chinese Academy of Medical Sciences, Wenzhou Medical University, Zhejiang University |
| NCT03961854 | Phase 1/Phase 2 (Phase 2) | Jul 31, 2019 | Juvenile Diabetes Research Foundation, University of Florida |
| NCT03961347 | Phase 1/Phase 2 (Phase 2) | Jul 31, 2019 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Florida |
| NCT03880760 | N/A | Aug 1, 2018 | China Medical University |
| NCT02349360 | N/A | Aug 1, 2015 | Juvenile Diabetes Research Foundation, University of Florida |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Florida | Academic/Hospital | 3 | 3 | 2 | 2015 |
| Zhejiang University | Academic/Hospital | 3 | 3 | 1 | 2025 |
| Juvenile Diabetes Research Foundation | Academic/Hospital | 2 | 0 | 2 | 2015 |
| China Medical University | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2025 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Government | 1 | 0 | 1 | 2019 |
| Wenzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2025 |
7 organizations
Page 1 / 1